The Absence of Release of the Plasminogen Activator After Venous Occlusion in a Fletcher Trait Patient

• References

• 1 Hathaway WE, Belhasen LP, Hathaway HS. Evidence for a new plasma thromboplastin factor I. Case report, coagulation studies and physicochemical properties. Blood 1965; 26: 521-532
• 2 Wuepper KD. Prekallikrein deficiency in man. J Exp Med 1973; 138: 1345-1355
• 3 Saito H, Ratnoff OD, Donaldson VH. Defective activation of clotting, fibrinolytic and permeability-enhancing systems in human Fletcher trait plasma. Circ Res 1974; 34: 641-651
• 4 Weiss AS, Gallin JI, Kaplan AP. Fletcher factor deficiency: a diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemo-tactic activity and IHnin generation. J Clin Invest 1974; 53: 622-633
• 5 Davie EW, Fujikawa K, Kurachi K, Kisiel W. The role of serine proteases in the blood coagulation cascade. Adv Enzymol 1979; 48: 277-318
• 6 Aznar JA, Espaiia F, Aznar J, Tascon A, Jimenez C. Fletcher factor deficiency: report of a new family. Scand J Haematol 1978; 21: 94-98
• 7 Saito H, Goodnough LT, Soria JS, Soria C, Aznar J, Espaiia F. Heterogeneity of human prekallikrein deficiency (Fletcher trait). Evidence that five of 18 cases are positive for cross-reacting material. N Eng J Med 1981; 305: 910-914
• 8 Espaiia F, Aznar J, Estelles A. Factor Xll-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher Factor deficient plasma gamma-globulin. J Lab Clin Med 1982; 100: 756-770
• 9 Klocking HP, Jablonowski CH, Markwardt F. Studies on the release of plasminogen activator from the isolated rat lung by serine proteinases. Thromb Res 1981; 23: 375-379